Cite
HARVARD Citation
Lobl, M. et al. (2020). Targeted next-generation sequencing of matched localized and metastatic primary high-risk SCCs identifies driver and co-occurring mutations and novel therapeutic targets. Journal of dermatological science. 99 (1), pp. 30-43. [Online].